Citigroup’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-125
| Closed | – | – | 5235 |
|
|
2022
Q3 | $0 | Buy |
+125
| New | – | ﹤0.01% | 5672 |
|
|
2022
Q2 | – | Sell |
-188
| Closed | – | – | 5936 |
|
|
2022
Q1 | $0 | Buy |
+188
| New | – | ﹤0.01% | 5795 |
|
|
2020
Q1 | – | Sell |
-454
| Closed | -$6K | – | 5253 |
|
|
2019
Q4 | $6K | Hold |
454
| – | – | ﹤0.01% | 4840 |
|
|
2019
Q3 | $5K | Sell |
454
-1,651
| -78% | -$18.2K | ﹤0.01% | 4811 |
|
|
2019
Q2 | $36K | Buy |
2,105
+842
| +67% | +$14.4K | ﹤0.01% | 4306 |
|
|
2019
Q1 | $42K | Sell |
1,263
-15
| -1% | -$499 | ﹤0.01% | 4133 |
|
|
2018
Q4 | $37K | Sell |
1,278
-15
| -1% | -$434 | ﹤0.01% | 4103 |
|
|
2018
Q3 | $80K | Sell |
1,293
-1,698
| -57% | -$105K | ﹤0.01% | 3749 |
|
|
2018
Q2 | $221K | Buy |
2,991
+1,814
| +154% | +$134K | ﹤0.01% | 2890 |
|
|
2018
Q1 | $77K | Buy |
1,177
+1,154
| +5,017% | +$75.5K | ﹤0.01% | 3521 |
|
|
2017
Q4 | $2K | Sell |
23
-98
| -81% | -$8.52K | ﹤0.01% | 4832 |
|
|
2017
Q3 | $14K | Buy |
121
+103
| +572% | +$11.9K | ﹤0.01% | 4134 |
|
|
2017
Q2 | $2K | Buy |
18
+2
| +13% | +$222 | ﹤0.01% | 4604 |
|
|
2017
Q1 | $2K | Buy |
+16
| New | +$2K | ﹤0.01% | 4663 |
|
|
2016
Q4 | – | Sell |
-99
| Closed | -$20K | – | 4996 |
|
|
2016
Q3 | $20K | Sell |
99
-159
| -62% | -$32.1K | ﹤0.01% | 4182 |
|
|
2016
Q2 | $33K | Sell |
258
-389
| -60% | -$49.8K | ﹤0.01% | 3922 |
|
|
2016
Q1 | $60K | Sell |
647
-934
| -59% | -$86.6K | ﹤0.01% | 4196 |
|
|
2015
Q4 | $320K | Buy |
1,581
+398
| +34% | +$80.6K | ﹤0.01% | 2697 |
|
|
2015
Q3 | $172K | Sell |
1,183
-18
| -1% | -$2.62K | ﹤0.01% | 2894 |
|
|
2015
Q2 | $256K | Sell |
1,201
-983
| -45% | -$210K | ﹤0.01% | 2587 |
|
|
2015
Q1 | $507K | Buy |
+2,184
| New | +$507K | ﹤0.01% | 2286 |
|